Currently on the verge of breaking out towards the higher 80s range. Also worth keeping an eye on the earnings report on 29 July. After the initial breakout it might trade sideways for a bit before a good earnings report could potentially boost it up a lot. Analyists are expecting a good report, with Merck's recent spin-off we've already had the ex-div ''drop'' that could lead to an unexpected beat of analysts' expectations.
PT 88
PT 88